NCT05652790

Brief Summary

The goal of this study is to assess the feasibility of recruitment, and barriers to delivery of an enhanced rehabilitation service, in patients surviving major trauma. The main questions it aims to answer are: are the investigators able to recruit patients to a research study are the investigators able to retain patients in the research study are the investigators able to identify appropriate primary outcome measures are the investigators able to identify barriers to future large-scale definitive trial or service delivery Participants will would be offered at least two sessions of the Enhanced Rehabilitation Programme (ERP), each lasting 60-120 minutes per week, delivered in the Manchester Institute of Health and Performance (MIHP). Participants not willing to travel to the MIHP, or declining to engage in the ERP, will be asked to join the Standard Care (SC) group. This group will provide questionnaire data and clinical outcome measure collection with their usual place of therapy. Researchers will compare the ERP group and the SC groups to assess any additional benefits to the ERP.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 24, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

November 25, 2022

Last Update Submit

April 30, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recruitment & retention into both arms of the trial

    Number of patients recruited to ERP

    12 months

Secondary Outcomes (10)

  • EQ-5D-L

    baseline, 3, 6 months and 12 months.

  • PHQ9

    baseline, 3, 6 months and 12 months

  • GAD7

    baseline, 3, 6 months and 12 months

  • LEFS

    baseline, 3, 6 months and 12 months

  • Two-minute walk test

    baseline, 3, 6 months and 12 months

  • +5 more secondary outcomes

Study Arms (2)

Enhanced Rehabilitation Programme (ERP)

EXPERIMENTAL

60-120 MINUTES OF ENHANCED REHABILITATION Manual Therapy Hydrotherapy Exercise Strength and Conditioning Programmes Gait re-education Pilates/ Yoga Cognitive and Vocational Rehabilitation Occupation Therapy Interventions eg. Anxiety Management, Pacing, Cognitive Behavioural Therapy

Procedure: Enhanced Rehabilitation Programme

Standard Care

OTHER

Standard care received at usual NHS facility

Procedure: Standard Care

Interventions

The ERP would be offered at least two sessions, each lasting 60-120 minutes per week, delivered in the Manchester Institute of Health and Performance. Interventions may include a combination of the following depending on the individual patient needs. Manual Therapy Hydrotherapy Exercise Strength and Conditioning Programmes Gait re-education Pilates/ Yoga Cognitive and Vocational Rehabilitation Occupation Therapy Interventions eg. Anxiety Management, Pacing, Cognitive Behavioural Therapy

Also known as: ERP
Enhanced Rehabilitation Programme (ERP)
Standard CarePROCEDURE

Standard care received at usual NHS facility

Also known as: SC
Standard Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants over 18 years old
  • Registered GP in Greater Manchester or Greater Manchester Resident.
  • Polytrauma or one or more complex /severe isolated injury
  • Rehabilitation goals (e.g., mobility, function, job retention/ return to work) identified using shared decision-making process
  • Patient able to enter programme 6-30 months post injury.
  • For the ERP patients willing to travel to the MIHP for their evaluation and treatment twice a week.
  • Participants with lower limb injuries that continue to have functional impairment.
  • Participants deemed well and safe enough to participate by clinical teams.
  • Normal ECG if previously reported to have abnormal ECG
  • Participants willing to consent to follow up over 12 months
  • Participants with the capacity to consent to the study.
  • Fully healed wounds and bone healed sufficiently to allow at least partial weight bearing

You may not qualify if:

  • Participants under the age of 18
  • Participants unable to provide informed consent
  • Participants with multiple pre-existing comorbidities that affect ability to participate in enhanced rehabilitation such as cognitive impairment, unstable angina.
  • Central motor neurological impairment affecting ability to participate in an enhanced rehab programme
  • Absence of functional disability affecting gait and / or function.
  • Plans for further surgery that will impact on gait or function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester University NHS Foundation Trust - St Mary's

Manchester, Greater Manchester, M13 9WL, United Kingdom

RECRUITING

MeSH Terms

Interventions

Standard of Care

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jason Wong, MD

    National Health Service, United Kingdom

    STUDY CHAIR

Central Study Contacts

Justine Theaker, PhD

CONTACT

Jason Wong, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pragmatic Prospective, multicentre feasibility non-randomised controlled trial
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2022

First Posted

December 15, 2022

Study Start

February 24, 2023

Primary Completion

August 1, 2024

Study Completion

April 1, 2025

Last Updated

May 1, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

no plan

Locations